Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 3Completed 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Depression 3Anxiety Disorders 3Neoplasms 2Ovarian Neoplasms 1Opioid-Related Disorders 1Neoplasm Metastasis 1Depressive Disorder 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Agnosia 1

Interventions

Cognitive Behavioral Therapy 4Psilocybin 3Therapeutics 2Oxygen 2Music Therapy 2Methods 2Waiting Lists 1Transurethral Resection of Prostate 1Touch 1Thyroidectomy 1TEMPO 1Surveys and Questionnaires 1Standard of Care 1Sertraline 1Selective Serotonin Reuptake Inhibitors 1Respiration 1Referral and Consultation 1Psychotherapy 1Pharmaceutical Preparations 1Paramedics 1Palliative Care 1Niacin 1Midazolam 1Methylphenidate 1Melatonin 1Ketamine 1Injections 1Hypnosis 1Glutamyl Aminopeptidase 1Fluoxetine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Anxiety Disorders × Psilocybin × Clear all
NCT07336238 2026-05-29

Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or Incurable Hematologic Malignancies

University of Washington

Phase 2 Recruiting
18 enrolled

Anxiety Disorders, Depression, Neoplasm Metastasis

NCT06200155 2026-04-16

Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy

M.D. Anderson Cancer Center

Phase 2 Recruiting
30 enrolled

Anxiety Disorders, Depression

NCT06801041 2026-04-16

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

M.D. Anderson Cancer Center

Phase 2 Recruiting
20 enrolled

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡